Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

8.99

-0.05 (-0.55%)

Mar 5, 2026, 1:13 PM GMT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
ACCRUFeR®/FeRACCRU®	32.18M	13.09M	5.50M	2.06M	14.18M
ACCRUFeR®/FeRACCRU® Growth	145.93%	137.95%	167.35%	-85.50%	1389.24%
Total	32.18M	13.09M	5.50M	2.06M	14.18M
Total Growth	145.93%	137.95%	167.35%	-85.50%	1389.24%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States of America ("USA")	29.27M	11.57M	3.53M	82.60K	-
United States of America ("USA") Growth	153.02%	228.13%	4168.87%	-	-
The Netherlands	2.14M	1.50M	1.78M	1.23M	-
The Netherlands Growth	43.28%	-15.77%	44.37%	-	-
Canada	320.00K	-	185.00K	-	-
Japan	322.00K	-	-	-	-
Republic of Korea	122.00K	20.00K	6.00K	744.73K	-
Republic of Korea Growth	510.00%	233.33%	-99.19%	-	-
Europe	-	-	-	-	995.30K
Europe Growth	-	-	-	-	30.02%
Asia	-	-	-	-	13.19M
Total	32.18M	13.09M	5.49M	2.06M	14.18M
Total Growth	145.93%	138.26%	167.01%	-85.50%	1389.24%

Source: S&P Global Market Intelligence.